Market Overview:
The global cardiac monitoring and diagnostic devices market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cardiovascular diseases, technological advancements in cardiac monitoring and diagnostic devices, and rising demand for home-based cardiac monitoring devices. Based on type, the electrocardiograph (ECG) segment is expected to account for the largest share of the global cardiac monitoring and diagnostic devices market in 2018. This segment is also projected to grow at a CAGR of 5.9% during the forecast period from 2018 to 2030. The ECG recorder segment is expected to grow at a CAGR of 6% during the same period owing to its growing demand for long-term patient tracking and diagnosis purposes.
Product Definition:
Cardiac monitoring and diagnostic devices are used to measure and monitor the heart's activity. This includes measuring heart rate, rhythm, blood pressure, and oxygen levels. These devices can help to diagnose heart conditions and monitor treatment progress.
Electrocardiograph:
Electrocardiography (ECG or EKG) is a test that records the heart's electrical activity. It is used to evaluate and detect heart problems, including arrhythmias (abnormal heartbeat), coronary artery disease, hypertension, and stroke. An ECG can also be used for diagnostic purposes to assess whether a patient has suffered a cardiac arrest or had an acute myocardial infarction (AMI).
ECG Recorder:
An ECG recorder is a portable device used to record the electrical activity of the heart. It is also known as Holter monitor or cardiac monitor. The device records and stores the patient’s heart rhythm for further analysis. An ECG recorder can be used in combination with an implantable loop recorder (ILR) or without ILR, depending on which type of study one performs.
The global market for ECG Recorder.
Application Insights:
The clinical application segment held the largest share of over 70.0% in 2017. The growth can be attributed to the increasing prevalence of cardiac diseases and rising awareness among individuals regarding early detection and treatment. Furthermore, an increase in investments for R&D for developing advanced products is also expected to drive the segment during the forecast period. For instance, in January 2018, Boston Scientific Corporation received FDA approval for its new product - Cardiac Rhythm Analyzer (CRA) - which is a wireless electrocardiograph that records electrical activity of the heart and transmits data via Bluetooth technology to a smartphone or tablet device with an app named QRS+. Such technological advancements are expected to fuel market growth during future years.
The hospital application segment is anticipated to witness significant growth over the forecast period owing to growing investments by governments as well as private institutions for developing advanced healthcare infrastructure along with rising incidences of cardiovascular diseases across various regions including North America, Europe, Asia Pacific.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of manufacturers, suppliers, and end users in this region. Moreover, increasing awareness about cardiac diseases and growing demand for advanced healthcare solutions are also expected to drive growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the next eight years owing to factors such as improving healthcare infrastructure and rising disposable income levels coupled with an increase in consumer awareness regarding early diagnosis of heart disorders.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising demand for early diagnosis and treatment of CVDs
- Technological advancements in cardiac monitoring and diagnostic devices
- Increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiac Monitoring and Diagnostic Devices Market Research Report
By Type
Electrocardiograph, ECG Recorder, Heart Rate Meter, ECG Telemetering, Others
By Application
Hospital, Clinical, Others
By Companies
Abbott, Applied Cardiac Systems, Bi-biomed, Bio Telemetry, BORSAM, EDAN, Fukuda Denshi, GE Healthcare, Hill-Rom, Innomed, iRhythm, Medicalgorithmics, Medicomp, Medtronic, MidMark, Mindray Medical, NIHON KOHDEN, Philips Healthcare, Schiller AG, Scottcare, Spacelabs Healthcare, Suzuken, VectraCor, Welch Allyn
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Cardiac Monitoring and Diagnostic Devices Market Report Segments:
The global Cardiac Monitoring and Diagnostic Devices market is segmented on the basis of:
Types
Electrocardiograph, ECG Recorder, Heart Rate Meter, ECG Telemetering, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinical, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Applied Cardiac Systems
- Bi-biomed
- Bio Telemetry
- BORSAM
- EDAN
- Fukuda Denshi
- GE Healthcare
- Hill-Rom
- Innomed
- iRhythm
- Medicalgorithmics
- Medicomp
- Medtronic
- MidMark
- Mindray Medical
- NIHON KOHDEN
- Philips Healthcare
- Schiller AG
- Scottcare
- Spacelabs Healthcare
- Suzuken
- VectraCor
- Welch Allyn
Highlights of The Cardiac Monitoring and Diagnostic Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Electrocardiograph
- ECG Recorder
- Heart Rate Meter
- ECG Telemetering
- Others
- By Application:
- Hospital
- Clinical
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiac Monitoring and Diagnostic Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cardiac monitoring and diagnostic devices are medical devices that measure heart function. These devices may be used to diagnose or monitor heart disease, abnormal rhythms, or other conditions.
Some of the key players operating in the cardiac monitoring and diagnostic devices market are Abbott, Applied Cardiac Systems, Bi-biomed, Bio Telemetry, BORSAM, EDAN, Fukuda Denshi, GE Healthcare, Hill-Rom, Innomed, iRhythm, Medicalgorithmics, Medicomp, Medtronic, MidMark, Mindray Medical, NIHON KOHDEN, Philips Healthcare, Schiller AG, Scottcare, Spacelabs Healthcare, Suzuken, VectraCor, Welch Allyn.
The cardiac monitoring and diagnostic devices market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiac Monitoring and Diagnostic Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiac Monitoring and Diagnostic Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiac Monitoring and Diagnostic Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiac Monitoring and Diagnostic Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiac Monitoring and Diagnostic Devices Market Size & Forecast, 2018-2028
4.5.1 Cardiac Monitoring and Diagnostic Devices Market Size and Y-o-Y Growth
4.5.2 Cardiac Monitoring and Diagnostic Devices Market Absolute $ Opportunity
Chapter 5 Global Cardiac Monitoring and Diagnostic Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Type
5.2.1 Electrocardiograph
5.2.2 ECG Recorder
5.2.3 Heart Rate Meter
5.2.4 ECG Telemetering
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cardiac Monitoring and Diagnostic Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinical
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiac Monitoring and Diagnostic Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cardiac Monitoring and Diagnostic Devices Analysis and Forecast
9.1 Introduction
9.2 North America Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Type
9.6.1 Electrocardiograph
9.6.2 ECG Recorder
9.6.3 Heart Rate Meter
9.6.4 ECG Telemetering
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinical
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cardiac Monitoring and Diagnostic Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Type
10.6.1 Electrocardiograph
10.6.2 ECG Recorder
10.6.3 Heart Rate Meter
10.6.4 ECG Telemetering
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinical
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cardiac Monitoring and Diagnostic Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Type
11.6.1 Electrocardiograph
11.6.2 ECG Recorder
11.6.3 Heart Rate Meter
11.6.4 ECG Telemetering
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinical
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cardiac Monitoring and Diagnostic Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Type
12.6.1 Electrocardiograph
12.6.2 ECG Recorder
12.6.3 Heart Rate Meter
12.6.4 ECG Telemetering
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinical
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cardiac Monitoring and Diagnostic Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Type
13.6.1 Electrocardiograph
13.6.2 ECG Recorder
13.6.3 Heart Rate Meter
13.6.4 ECG Telemetering
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cardiac Monitoring and Diagnostic Devices Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinical
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiac Monitoring and Diagnostic Devices Market: Competitive Dashboard
14.2 Global Cardiac Monitoring and Diagnostic Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Applied Cardiac Systems
14.3.3 Bi-biomed
14.3.4 Bio Telemetry
14.3.5 BORSAM
14.3.6 EDAN
14.3.7 Fukuda Denshi
14.3.8 GE Healthcare
14.3.9 Hill-Rom
14.3.10 Innomed
14.3.11 iRhythm
14.3.12 Medicalgorithmics
14.3.13 Medicomp
14.3.14 Medtronic
14.3.15 MidMark
14.3.16 Mindray Medical
14.3.17 NIHON KOHDEN
14.3.18 Philips Healthcare
14.3.19 Schiller AG
14.3.20 Scottcare
14.3.21 Spacelabs Healthcare
14.3.22 Suzuken
14.3.23 VectraCor
14.3.24 Welch Allyn
